Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Conference News AHA 2024

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

Yael L. Maxwell

November 17, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Conference News AHA 2021

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Yael L. Maxwell

November 15, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Features

Roughly 80% of ESC Guideline Writers Have Financial COIs

Michael O'Riordan

April 01, 2021

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Industry News

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

June 01, 2020

News Daily News

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

Shelley Wood

December 02, 2019

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Daily News

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

Todd Neale

June 25, 2018

News Daily News

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

Michael O'Riordan

May 01, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Shelley Wood

March 12, 2018

News Daily News

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

L.A. McKeown

February 09, 2018

News Conference News ISC 2018

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

Todd Neale

January 25, 2018

News Daily News

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

L.A. McKeown

January 02, 2018

News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Shelley Wood

November 09, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

Advertisement

ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Bentracimab Rapidly, Safely Reverses Ticagrelor in Early REVERSE-IT Data

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Roughly 80% of ESC Guideline Writers Have Financial COIs

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

CeloNova Announces Enrollment Completion of World’s First Randomized Control, 14-Day DAPT Trial

Switch Anticoagulants for A-fib Patients Needing a Stent? RE-DUAL PCI Insights

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

NOACs Carry Lower MI Risk vs Warfarin in Real-world Study

Women Underrepresented in Pivotal Studies Leading to FDA Drug Approval

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Research Series Sheds Light on Questions Surrounding Stroke Risk in Women

COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke

NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

TCTMD’s Top 10 Most Popular Stories for October 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content